Related Experiment Videos

Inhibition of c-Src protects paraquat induced microvascular endothelial injury by modulating caveolin-1

Yu Huang1, Qing He2

  • 1Department of Intensive Care Medicine, The Third People's Hospital of Chengdu, The Second Affiliated Hospital of Chengdu, Chongqing Medical University, Chengdu, China.

Insights

Paraquat causes lung injury by increasing endothelial permeability via c-Src and caveolin-1 phosphorylation. Inhibiting c-Src may protect against paraquat-induced acute lung injury (ALI).

Area of Science:

  • Cell Biology
  • Toxicology
  • Pulmonary Medicine

Background:

  • Paraquat is a herbicide that can cause acute lung injury (ALI).
  • The exact mechanisms of paraquat-induced ALI are not fully understood.
  • C-Src kinase is involved in regulating endothelial barrier function and ALI pathogenesis.

Purpose of the Study:

  • To investigate the role of c-Src in paraquat-induced endothelial dysfunction and ALI.
  • To explore the involvement of caveolin-1 phosphorylation and caveolae trafficking in paraquat toxicity.
  • To assess the potential therapeutic effects of targeting c-Src in paraquat-induced ALI.

Main Methods:

  • Endothelial cell cultures were exposed to paraquat.
  • Cell toxicity, reactive oxygen species (ROS) production, and albumin permeability were measured.
  • C-Src was depleted using small interfering RNA (siRNA).
  • Caveolin-1 phosphorylation and caveolae formation were analyzed.

Main Results:

  • Paraquat induced endothelial cell toxicity, increased ROS, and enhanced albumin permeability.
  • Paraquat exposure led to increased caveolin-1 phosphorylation and caveolae trafficking.
  • C-Src depletion significantly reduced paraquat-induced toxicity, caveolin-1 phosphorylation, and hyperpermeability.
  • N-acetylcysteine (NAC) did not protect against paraquat-induced endothelial toxicity.

Conclusions:

  • Paraquat increases endothelial permeability through c-Src-dependent caveolin-1 phosphorylation.
  • C-Src plays a critical role in paraquat-induced endothelial barrier dysfunction.
  • Targeting c-Src may offer a therapeutic strategy for managing paraquat-induced ALI.

Related Concept Videos